New trial of LifeCell's surgical matrix kicks off
This article was originally published in Clinica
Executive Summary
Sports medicine specialist Tornier and Kinetic Concepts, Inc (KCI) subsidiary LifeCell have begun a trial of Conexa, a reconstructive tissue matrix for the surgical repair of large rotator cuff tears. The rotator cuff is a group of four shoulder muscles and their tendons; tears to the muscles are often sustained by sportspeople such as tennis players, baseball pitchers and fast bowlers in cricket.
You may also be interested in...
ITF Has A Fight On Its Hands In Duchenne
The group’s new muscular dystrophy pill seems unlikely to cut into Sarepta’s sales.
AbbVie Needs To Freshen Up
With half of its 2023 sales coming from aging blockbusters like Humira and Botox, AbbVie needs new blood.
AstraZeneca Pays $2bn To Keep Up With The Joneses
Bristol Myers Squibb and Lilly have recently done billion-dollar radiopharmaceuticals deals, and now the UK group wants a piece of the market. But can it make its Fusion fusion work?